[1] Burns J, Varughese R, Ganigara M, et al. Neurodevelopmental outcomes in congenital heart disease through the lens of single ventricle patients[J]. Current Opinion in Pediatrics, 2021, 33(5):535-542. [2] Cao L, Du Y, Zhang M, et al. High maternal blood lipid levels during early pregnancy are associated with increased risk of congenital heart disease in offspring[J]. Acta Obstetricia et Gynecologica Scandinavica, 2021, 100(10):1806-1813. [3] Westaby J D, Cooper S T E, Edwards K A, et al. Insights from examination of hearts from adults dying suddenly to the understanding of congenital cardiac malformations[J]. Clinical Anatomy, 2020, 33(3):394-404. [4] Krishnan R, Deal L, Chisholm C, et al. Concordance between obstetric anatomic ultrasound and fetal echocardiography in detecting congenital heart disease in high-risk pregnancies[J]. Journal of Ultrasound in Medicine, 2021, 40(10):2105-2112. [5] 王玉波,高艳多,贺勇,等.胎儿心脏畸形孕早期筛查中脐静脉导管血流频谱参数与染色体异常的关系分析[J].中国优生与遗传杂志, 2020, 28(1):83-85, 91. [6] 刘志宝,李光,李静,等.孕早期胎儿脐静脉导管彩色多普勒超声血流频谱参数结合血清蛋白测定在先天性心脏畸形中的诊断价值及与胎儿染色体异常关系[J].中国医刊, 2022, 57(4):456-461. [7] 裘品丹,袁晓丹,谢旭敏. 11~13~(+6)周胎儿静脉导管血流频谱异常在胎儿染色体异常和心脏畸形评估中的作用[J].现代医用影像学, 2018, 27(2):364-367. [8] 焦敬,赵金惠.探讨孕中期不同时段超声检查对胎儿心脏畸形的诊断价值及对胎儿心脏畸形检出率的影响[J].中国优生与遗传杂志, 2020, 28(5):628-630. [9] 罗丽芳,吴惠双,杜燕飞,等.静脉导管多普勒血流频谱筛查对孕早期胎儿先天性心脏病的临床意义[J].现代医用影像学, 2020, 29(4):623-625. [10] 许彬,寇燕妮.孕早期超声检测颈部透明层增厚与静脉导管频谱异常在筛查胎儿复杂先天性心脏畸形中的价值[J].中国优生与遗传杂志, 2020, 28(12):1507-1510. [11] 周海红.孕中期不同时段超声检查对胎儿心脏畸形的诊断价值[J].中国优生与遗传杂志, 2019, 27(1):66-68, 2. [12] 李宜,毛晓惠.四维超声成像技术诊断孕中期胎儿心脏畸形的价值探讨[J].山西医药杂志, 2020, 49(16):2111-2113. [13] 赵艳春,吕国荣,李敏,等.四维超声STIC技术检测中孕早期胎儿心脏畸形[J].中国医学影像技术, 2013, 29(2):260-263. [14] 戴青里,刘燕,骆志玲.二维联合四维超声诊断产前胎儿心脏畸形的临床研究[J].昆明医科大学学报, 2015, 36(5):65-68. [15] Rizk J. 4D flow MRI applications in congenital heart disease[J]. European Radiology, 2021, 31(2):1160-1174. [16] 谢维维,解左平,邱合荣.中孕早期观察胎儿静脉导管血流频谱a谷形态筛查胎儿心脏畸形的意义[J].中国优生与遗传杂志, 2017, 25(4):106-107. [17] 张伟娟,张蕊,陈文敏,等.孕早期胎儿颈项透明层厚度联合孕中期四维超声在体表畸形筛查中的诊断价值[J].现代医用影像学, 2021, 30(8):1567-1570. [18] 刘凤林,许占英,李建荣.胎儿颈项透明层厚度超声与孕中期四维彩色多普勒超声联合诊断胎儿畸形的价值分析[J].中国药物与临床, 2019, 19(10):1617-1618. [19] 黄正妹.孕11~13周+6NT超声检查联合孕中期四维彩超筛查胎儿畸形的价值[J].现代诊断与治疗, 2021, 32(23):3809-3810. |